Arquivamento - Art. 36 §1° da LPI
#11.2
12/03/2024
RPI 2813
Application data
Number
112019009992Type
Filing
Publication
PCT
US2017061871 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 12/03/2024. We update with every new RPI gazette, published weekly.
Applicants
ABIDE THERAPEUTICS, INC.
US
H. LUNDBECK A/S
DK
LUNDBECK LA JOLLA RESEARCH CENTER, INC.
US
Inventors
C. G. (pessoa física)
US
H. T. (pessoa física)
US
I. G. (pessoa física)
US
J. Z. (pessoa física)
US
N. W. (pessoa física)
US
IPC Classification
Priority claims
US
62/423,124 · 11/16/2016
US
62/545,857 · 08/15/2017
Abstract
Aqui são fornecidas formulações farmacêuticas caracterizada por abranger um inibidor de lipase monoacilglicerol (MAGL), ou um sal farmaceuticamente aceitável do mesmo e pelo menos um excipiente farmaceuticamente aceitável.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
12/03/2024
RPI 2813
#6.1
08/20/2024
RPI 2798
#6.23
01/25/2022
RPI 2664
#15.35
10/05/2021
RPI 2648
#25.1
02/09/2021
RPI 2614
#25.4
01/19/2021
RPI 2611
#1.3
08/27/2019
RPI 2538
#1.1
05/28/2019
RPI 2525
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.